Get the Stockscreener App
0.6797
6.54%
-0.0476
AEON Biopharma Inc. stock is traded at $0.6797, with a volume of 130.91K.
It is down -6.54% in the last 24 hours and down -14.74% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.7273
Open:
$0.72
24h Volume:
130.91K
Relative Volume:
0.18
Market Cap:
$7.68M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-13.94%
1M Performance:
-14.74%
6M Performance:
-92.66%
1Y Performance:
-99.18%
1-Day Range:
$0.6542
$0.7236
1-Week Range:
$0.6542
$0.82
52-Week Range:
$0.375
$115.57
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.6797 | 8.22M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
AEON Biopharma Inc. stock trend forecastDaily Pick Forecast with Entry Zones - Newser
Predicting AEON Biopharma Inc. trend using moving averagesAsset Safety Selection Using Quantitative Analysis - Newser
How to use a screener to detect AEON Biopharma Inc. breakoutsGrowth Projection Summary for Long-Term Investors - Newser
What technical models suggest about AEON Biopharma Inc.’s comebackLow Risk High Confidence Watchlist Builder - Newser
Why is AEON Biopharma Inc. stock attracting strong analyst attentionStock Strategy Picks For 2025 - jammulinksnews.com
Is AEON Biopharma Inc. stock entering bullish territoryIntraday Price Forecast Using Volume Models - Newser
How volatile is AEON Biopharma Inc. stock compared to the marketLow Risk Growth Plan With Low Risk - jammulinksnews.com
AEON Biopharma Inc. stock volume spike explainedAutomated AI Forecast with Trading Alerts - Newser
Why AEON Biopharma Inc. stock attracts strong analyst attentionProfit Target Planning with Exit Confidence - Newser
Fibonacci Levels Suggest Recovery for AEON Biopharma Inc.AI Screening for Swing Trade Picks Finds Momentum - metal.it
RSI Crosses Above 30 for AEON Biopharma Inc. — Reversal in Sight - metal.it
Short Interest Drops in AEON Biopharma Inc. After RallyWeekly Watchlist of High Movers Released - metal.it
What are the latest earnings results for AEON Biopharma Inc.Pre Market Insights For Beginners - jammulinksnews.com
What is AEON Biopharma Inc. company’s growth strategyFinancial News Planner For Beginners - jammulinksnews.com
Momentum divergence signals in AEON Biopharma Inc. chartSmart Risk Entry Zone Technical Analysis - Newser
Custom watchlist performance reports with AEON Biopharma Inc.Safe and Scalable Return Strategy Blueprint - Newser
Ranking AEON Biopharma Inc. among high performing stocks via tools High Probability Trade Outcome Prediction - Newser
How does AEON Biopharma Inc. generate profit in a changing economyBuild wealth faster with expert stock selection - jammulinksnews.com
When is AEON Biopharma Inc. stock expected to show significant growthOutstanding capital returns - jammulinksnews.com
Should I hold or sell AEON Biopharma Inc. stock in 2025Unstoppable trading performance - jammulinksnews.com
How strong is AEON Biopharma Inc. company’s balance sheetCapitalize on market trends with confidence - jammulinksnews.com
How Efficient Is AEON Biopharma Inc. at Controlling Operating CostsFree Predictions - metal.it
Intrinsic Value of AEON Biopharma Inc. Stock: Is It Undervalued or OvervaluedFree Stock Selection - Newser
Is AEON Biopharma Inc. a good long term investmentExceptional profit margins - PrintWeekIndia
What analysts say about AEON Biopharma Inc. stockPhenomenal returns - PrintWeekIndia
Will AEON Biopharma Inc. stock benefit from AI tech trendsUnmatched profit growth - jammulinksnews.com
What drives AEON Biopharma Inc. stock priceFree Capital Efficiency Planning - PrintWeekIndia
Penny health care stocks upcoming release phase 2 and phase 3 in August - AInvest
AEON Biopharma Inc. Stock Analysis and ForecastRapid growth opportunities - jammulinksnews.com
why aeon biopharma inc. stock attracts strong analyst attentionFree Investment Community - Newser
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Cap:
|
Volume (24h):